Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit

2002 ◽  
Vol 283 (3) ◽  
pp. H1099-H1107 ◽  
Author(s):  
Thorsten Reffelmann ◽  
Robert A. Kloner

The aim was to define the degree and time course of reperfusion-related expansion of no reflow. In five groups of anesthetized, open-chest rabbits (30-min coronary occlusion and different durations of reperfusion), anatomic no reflow was determined by injection of thioflavin S at the end of reperfusion and compared with regional myocardial blood flow (RMBF; radioactive microspheres) and infarct size (triphenyltetrazolium). The area of no reflow progressively increased from 12.2 ± 4.2% of the risk area after 2 min of reperfusion to 30.8 ± 3.1% after 2 h and 34.9 ± 3.3% after 8 h and significantly correlated with infarct size after 1 h of reperfusion ( r = 0.88–0.97). This rapid expansion of no reflow predominantly occurred during the first 2 h, finally encompassing ∼80% of the infarct size, and was accompanied by a decrease of RMBF within the risk area, being hyperemic after 2 min of reperfusion (3.78 ± 0.75 ml · min−1 · g−1) and plateauing at a level of ∼0.9 ml · min−1 · g−1 by 2 and 8 h of reperfusion (preischemic RMBF: 2.06 ± 0.01 ml · min−1 · g−1). The development of macroscopic hemorrhage lagged behind no reflow, was closely correlated with it, and may be the consequence of microvascular damage.

2003 ◽  
Vol 284 (4) ◽  
pp. H1134-H1141 ◽  
Author(s):  
Thorsten Reffelmann ◽  
Robert A. Kloner

Two independent cardioprotective interventions, Na+/H+ exchange inhibition and ischemic preconditioning (PC), were investigated with respect to differential effects on microvascular and myocardial salvage in anesthetized rabbits (30 min of ischemia, 180 min of reperfusion). Cariporide (Car, 300 μg/kg) administered before occlusion and PC reduced infarct size (IS) as measured by triphenyltetrazolium staining [control, 46.0 ± 4.2% of risk area (RA); Car, 17.6 ± 3.7% ( P< 0.01); PC, 27.5 ± 4.1% ( P < 0.01)] and concomitantly decreased the area of anatomic no reflow (ANR) as measured by thioflavin S staining [control, 40.4 ± 3.7%; Car, 19.0 ± 2.9% ( P < 0.01); PC, 26.9 ± 3.4% ( P < 0.05)]. Regional myocardial blood flow (RMBF, measured by radioactive microspheres) in the RA, which deteriorated between 30 and 180 min of reperfusion (control, from 79 ± 6 to 26 ± 2% of nonischemic flow), was shifted to higher values with both treatments [Car, from 110 ± 12 to 49 ± 7% ( P < 0.05); PC, from 109 ± 8 to 38 ± 6% ( P < 0.05)]. However, neither intervention uncoupled the close relationship between IS and ANR ( r= 0.92–0.95) or RMBF. Car given at reperfusion did not alter IS, ANR, RMBF, or the close interrelationships. Because size and spatial distribution of no reflow and myocardial necrosis remained closely coupled with independent cardioprotective interventions, a potential causal connection between microvascular and myocardial salvage is discussed.


2002 ◽  
Vol 282 (2) ◽  
pp. H766-H772 ◽  
Author(s):  
Thorsten Reffelmann ◽  
Sharon L. Hale ◽  
Guohu Li ◽  
Robert A. Kloner

No reflow after acute myocardial infarction is an important predictor of infarct size and clinical outcome. However, the exact relationship between no reflow and infarct size remains to be determined, particularly because no reflow may progress during the time course of reperfusion. Control groups of five previous protocols using the anesthetized, open-chest rabbit model of coronary artery occlusion and reperfusion were retrospectively analyzed with respect to the correlation between regional myocardial blood flow (RMBF; radioactive microspheres) and infarct size (triphenyltetrazolium chloride) in the course of reperfusion. After 30 min of occlusion, reflow (defined as the ratio of RMBF in the risk area divided by the nonischemic area) declined from hyperemic values after 30 min of reperfusion (reflow ratio: 1.33 ± 0.81; RMBF in the risk area at the same time point: 2.25 ± 1.04 ml · g−1 · min−1) to 0.47 ± 0.22 after 120 min and 0.46 ± 0.13 after 180 min of reperfusion. After 120 min of ischemia, reflow at 30 min of reperfusion was 0.49 ± 0.24 and deteriorated by 120 min of reperfusion (0.26 ± 0.15). In every group, there was a strong correlation between infarct size and reflow (correlation coefficients: −0.62 to −0.82). The lines of regression for the groups with assessment of RMBF after 120 or 180 min of reperfusion were nearly identical regardless of the duration of ischemia. Thus microvascular reperfusion injury led to a striking decrease in RMBF within the first 2 h of reperfusion, with infarct size as the major determinant of reflow at a given time point of reperfusion.


Sign in / Sign up

Export Citation Format

Share Document